Skip to main content
. 2021 Feb 25;14:179–183. doi: 10.2147/CCID.S300402

Table 1.

Results by Mode of Exercise (Hospital and Mixed Practice/Private Practice)

Hospital/Mixed Practice (n= 175) Liberal Practice (n=131) Chi Square
Prescription of methotrexate 68.9% (n=115/167) 34.6% (n=44/127) ≤ 0.001
MD: 8 MD: 4
Reason for not prescribing methotrexate n=52 n= 83
- Absence of eligible patients −57.7% (n=30/52) −39.8% (n=33/83)
- No marketing authorisation for AD −46.1% (n=24/52) −48.2% (n=40/83)
- No experience with methotrexate −9.6% (n=5/52) −34.9% (n=29/83)
- Lack of training/information −21.1% (n=11/52) −50.6% (n=42/83)
Prescription of cyclosporine 75.1% (n=124/165) 10.3% (n=13/126) ≤ 0.001
MD: 10 MD: 5
Reason for not prescribing cyclosporine n= 41 n=113
  • Absence of eligible patients

−26.8% (n=11/41) −23.9% (n=27/113)
  • Lack of knowledge of the recommendations

−0 −13.3% (n=15/113)
  • No experience with cyclosporine

−78% (n=32/41) −79.6% (n=90/113)
  • Lack of training/information

−41.5% (n=17/41) −56.6% (n=64/113)
  • Requires initial hospital prescription

−4.9% (n=2/41) −40.7% (n=46/113)
Prescription of oral corticoids 7.9% (n=13/164) 12.1% (n=15/124) NS
MD: 9 MD: 7
Prescription of dupilumab 80.5% (n=132/167) 25% (n=31/124) ≤ 0.001
MD: 8 MD: 7
Absence of use of score before methotrexate prescription 39.5% (n=66/167) 64.6% (n=82/127) ≤ 0.001
MD: 8 MD: 4
Absence of use of score before cyclosporine prescription 35.1% (n=58/165) 84.9% (n=107/126) ≤ 0.001
MD: 10 MD: 5

Abbreviations: MD, missing data; AD, atopic dermatitis, NS, not significant.